europe brain aneurysm treatment Market

The Europebrain aneurysm treatment market is expected to reachUS$ 1,768.43 Mn by 2027 from US$ 644.84 Mn in 2019. The market is anticipated to grow at a CAGR of 13.6% from 2020 to 2027.

The growth of the Europe brain aneurysm treatment market is ascribed to the growing prevalence of neurological disorders, and increasing research and development to boost product innovation for better diagnosis. However, high cost associated with the procedure hampers the growth of market in this region.

The prevalence of brain aneurysms is rising in many European countries. For instance, in France, ~2.5% of the adult population suffers intracranial aneurysms.Further, certain strategic initiatives by the government to treat patients suffering from brain aneurysm are also driving the growth of the brain aneurysm market in Europe. For instance, the French government implemented analysis of treatment by endovascular approach of nonruptured aneurysms. The program was conducted to check the feasibility of endovascular approach for the treatment of nonrupturedbrain aneurysms.

The Europebrain aneurysm treatment market, based on type,is segmented into surgery and medication. In 2019, the medicationsegment held a larger share of the market; however, thesurgery segment is expected to register a higher CAGRin the market during the forecast period.The Europebrain aneurysm treatment market, based on condition,is segmented into unruptured aneurysm and ruptured aneurysm. In 2019, unruptured aneurysmheld a larger share of the market; however, the ruptured aneurysmsegment is expected to register a higher CAGRduring 2020?2027. Further, the Europebrain aneurysm treatment market, based on end user,is segmented into hospitals and clinics. In 2019, the hospitals segment held a larger share of the market; however, the market for the clinicssegment is expected to grow at a higher CAGRduring the forecast period.

A few of the major primary and secondary sources involved in the process of preparing the report on the brain aneurysm treatment market are theWorld Health Organization, European Federation of Pharmaceuticals Industries Associations, and European Medical Association.